MML Investors Services LLC Buys 168 Shares of Solventum Co. (NYSE:SOLV)

MML Investors Services LLC raised its stake in Solventum Co. (NYSE:SOLV) by 3.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,345 shares of the company’s stock after buying an additional 168 shares during the period. MML Investors Services LLC’s holdings in Solventum were worth $373,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Trian Fund Management L.P. increased its holdings in Solventum by 32.9% during the 3rd quarter. Trian Fund Management L.P. now owns 7,126,255 shares of the company’s stock valued at $496,842,000 after purchasing an additional 1,765,676 shares during the period. State Street Corp lifted its holdings in Solventum by 3.1% in the third quarter. State Street Corp now owns 6,107,550 shares of the company’s stock worth $425,818,000 after buying an additional 185,938 shares during the period. Davis Selected Advisers bought a new stake in Solventum during the 2nd quarter valued at approximately $273,070,000. Nuance Investments LLC purchased a new position in shares of Solventum during the 2nd quarter worth approximately $115,829,000. Finally, Newport Trust Company LLC bought a new position in shares of Solventum in the 2nd quarter worth approximately $98,976,000.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on SOLV shares. Morgan Stanley lifted their target price on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. BTIG Research assumed coverage on Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating for the company. Wolfe Research started coverage on shares of Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating for the company. Mizuho began coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective on the stock. Finally, Piper Sandler lifted their target price on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $68.29.

Solventum Trading Down 0.1 %

Shares of NYSE SOLV opened at $66.56 on Wednesday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The business’s 50 day moving average is $70.84 and its two-hundred day moving average is $63.69. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.